Outset Medical, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $119.5M | $113.7M | $130.4M | $115.4M | $102.6M |
| Gross profit | $46.8M | $38.6M | $29.0M | $17.8M | $7.6M |
| Operating income | -$66.7M | -$113.4M | -$169.8M | -$161.0M | -$130.5M |
| Operating expenses | $113.5M | $151.9M | $198.8M | $178.9M | $138.1M |
| Cost of revenue | $72.7M | $75.1M | $101.4M | $97.5M | $95.0M |
| Cash from operations | -$46.3M | -$116.3M | -$131.4M | -$145.7M | -$130.3M |
| Capital expenditure | $798,000 | $912,000 | $3.4M | $8.3M | $3.1M |
| Free cash flow | -$47.1M | -$117.2M | -$134.8M | -$154.1M | -$133.4M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $264.5M | $275.8M | $313.8M | $400.1M | $463.5M |
| Total liabilities | $137.5M | $249.0M | $190.9M | $154.1M | $89.4M |
Shares outstanding 18.5M · Free float 74.4%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.